📈
📈 Business
Moderna shares double on cancer vaccine trial results — Trump earned up to $91,000
Moderna shares surged more than 100% on Wednesday after its personalised mRNA cancer vaccine posted positive Phase 3 trial results. US President Donald Trump also benefited from the rally, with disclosed trading records showing he earned between approximately $27,300 and $91,200 over a five-month period, according to Benzinga.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!